Bayesian nonparametric statistics: A new toolkit for discovery in cancer research.
Peter F ThallPeter MuellerYanxun XuMichele GuindaniPublished in: Pharmaceutical statistics (2017)
Many commonly used statistical methods for data analysis or clinical trial design rely on incorrect assumptions or assume an over-simplified framework that ignores important information. Such statistical practices may lead to incorrect conclusions about treatment effects or clinical trial designs that are impractical or that do not accurately reflect the investigator's goals. Bayesian nonparametric (BNP) models and methods are a very flexible new class of statistical tools that can overcome such limitations. This is because BNP models can accurately approximate any distribution or function and can accommodate a broad range of statistical problems, including density estimation, regression, survival analysis, graphical modeling, neural networks, classification, clustering, population models, forecasting and prediction, spatiotemporal models, and causal inference. This paper describes 3 illustrative applications of BNP methods, including a randomized clinical trial to compare treatments for intraoperative air leaks after pulmonary resection, estimating survival time with different multi-stage chemotherapy regimes for acute leukemia, and evaluating joint effects of targeted treatment and an intermediate biological outcome on progression-free survival time in prostate cancer.
Keyphrases
- free survival
- clinical trial
- prostate cancer
- data analysis
- neural network
- primary care
- single cell
- machine learning
- phase ii
- mental health
- healthcare
- pulmonary hypertension
- open label
- double blind
- radical prostatectomy
- study protocol
- public health
- young adults
- radiation therapy
- phase iii
- health information
- squamous cell
- cancer therapy
- lymph node metastasis
- smoking cessation